文献速递腹部技术与安全CTMR

CT与钆塞酸二钠增强MRI联合弥散加权成像的肝脏影像报告和数据系统评估

Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.
PubMed 文献 · Eur Radiol · 2017-04-03

研究纳入421例患者共445个肝脏观察灶,评估LI-RADS主要影像特征在增强CT与钆塞酸二钠增强MRI上的表现,并检验肝胆期信号强度联合弥散加权成像能否作为LI-RADS主要特征。结果显示包膜和廓清表现在CT与MRI间不一致率较高,修改版LI-RADS特异度(77.1-79.2%)高于v2014版(75%),但ROC曲线下面积无显著差异。

要点

  • 包膜表现是CT与MRI间不一致率最高的主要特征(32.7%),其次为廓清表现(22.2%)。
  • 修改版LI-RADS特异度77.1-79.2%高于v2014版75%,但ROC曲线下面积无显著差异。
  • 肝胆期联合弥散加权成像可能作为LI-RADS主要特征,但尚需进一步验证。

核心结论

  • 肝脏观察灶的包膜和廓清表现在CT与MRI间存在显著不一致,钆塞酸二钠增强MRI联合弥散加权成像可能作为LI-RADS的主要特征。

研究设计与样本

  • 研究纳入421例患者共445个观察灶,评估增强CT和钆塞酸二钠增强MRI的LI-RADS主要特征及肝胆期和弥散加权成像特征,比较LI-RADS v2014与修改版LI-RADS的LR-5诊断效能。

关键影像表现/征象

  • 肝细胞癌中包膜表现在CT与MRI间不一致率最高(32.7%),其次为廓清表现(22.2%)。
  • 同一观察灶可能因所用影像检查不同而被归为不同LI-RADS类别。

诊断标准与关键数值

  • LI-RADS v2014的LR-5特异度为75%,低于修改版LI-RADS的77.1-79.2%。
  • 修改版LI-RADS的ROC曲线下面积为0.755-0.775,与v2014版的0.709无显著差异(p>0.05)。

临床应用与阅片要点

  • 对LR-3和LR-4观察灶应同时进行CT和MRI检查。
  • 钆塞酸二钠增强MRI联合弥散加权成像可能作为LI-RADS的主要特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess major imaging features of Liver Imaging Reporting and Data System (LI-RADS) on contrast-enhanced CT and gadoxetic acid-enhanced MRI and to estimate whether the combination of signal intensity favouring HCC on hepatobiliary phase (HBP) and diffusion-weighted images (DWI) can act as a major feature in LI-RADS.

METHODS: Four hundred twenty one patients with 445 observations were included. Major features of LI-RADS on CT and MRI as well as HBP and DWI features were assessed. Diagnostic performances of LR-5 according to LI-RADS v2014 and modified LI-RADS which incorporate combination of HBP and DWI were assessed. Pairwise comparisons of the receiver operating characteristic (ROC) curves were performed.

RESULTS: For HCCs, capsule appearance had the highest rate of discordance between CT and MRI (32.7%), followed by washout appearance (22.2%). Specificity (75%) of LR-5 of LI-RADS v2014 was lower than that (77.1-79.2%) of modified LI-RADS. Area under the ROC curve of modified LI-RADS (0.755-0.775) was not significantly different from that of LI-RADS v 2014 (0.709) (p > 0.05).

CONCLUSIONS: There were substantial discordances between CT and MRI for capsule and washout appearances in hepatic observations, and combination of gadoxetic acid-enhanced MRI and DWI might be able to be incorporated as a major feature of LI-RADS.

KEY POINTS: • Major imaging features of LI-RADS showed substantial discordances on CT and MRI. • An observation may be categorized differently depending on used imaging exam. • CT and MRI should both be performed for LR-3 and LR-4 observations. • Combination of gadoxetic acid-enhanced MRI and DWI may be a major feature.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cha DI, Jang KM, Kim SH, et al. Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging. Eur Radiol. 2017. PMID: 28374073. doi:10.1007/s00330-017-4804-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。